
Penrose Stairs
I talk quite a bit about self-referential market dynamics in these pages.
Some of those discussions likely come across as the stream-of-consciousness musings of someone who's been doing this (whatever "this" is) too long.
Often, when you become intimately familiar with a subject, every aspect of it starts to look like a reflection of some other aspect, usually because it is. It's only once you immerse yourself in something for years or, more aptly, decades, with no breaks, that you understand
Value vs growth is a rabbit hole in this environment. Better to focus on sectors that may not be as affected by rising short rates and slower growth. Big pharma might seem like a logical choice as an example. There are others as well, but trying to parse this as a growth vs value or quality etc may be aiming at the wrong target.